MedPath

MIDAZOLAM INJECTION USP

MIDAZOLAM INJECTION USP

Approved
DIN Number

02553104

Drug Class

Human

Market Date

N/A

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02553104
AIG Number0119935002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD08 MIDAZOLAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIDAZOLAMActive
Strength: 1 MG / ML
Monograph: MIDAZOLAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.